n vitro Antiviral Activity of the Favipiravir and their 6- and 3-O-Substituted derivatives Against Coronovirus: Acetylation leads Improvement of Antiviral Activity

Synthesis and antiviral evaluation of a new series of functionalized favipiravir The present manuscript described the optimization of the favipiravir as antiviral against in vitro bovine and human models of coronavirus, which was focused on two chemical functionalizations in pyrazine-structure: (i) functionalization at 6-position using halogens (F, Cl, Br and I) and hydrogen, and (ii) functionalization of 3-hydroxyl using different removal groups like acetyl, triflate, methanosulphonic and benzylic moieties. The first functionalization seeks to interpret the role of the tautomerism in the reactivity of the 3-hydroxypyrazine to form the active T07-RTP (T07-ribonucleoside 5′-triphosphate) metabolite, which was a question generated from previous reports in models of influenza (Huchting, J. et al. J. Med. Chem. 2018, 61, 6193-6210; De Almeida La Porta, F. et al. RSC Adv. 2021, 11, 35228 and other reports). Previously, we performed a full study of the tautomerism of this type of 3-hydroxy-2-pyrazinecarboxamides in solid state and in solution (J. Org. Chem. 2023, 88, 10735-10752) and we found that the keto-tautomerization in solution can be favored with diminution of halogen electronegativity as follows: 6-H >> 6-I > 6-Br >> 6-Cl > 6-F. That issue seeks to verify if the modulation of the keto-tautomerization by 6-halogen substitution can favor the antiviral response in coronavirus models, which is novel to the best of our knowledge. Regarding the second functionalization, we seek to improve the cell penetration with the functionalization of the 3-hydroxyl moiety using removal lipophilicity moieties, whose final target was to enhance the antiviral response. The bioavailability of the favipiravir is one of its most significant disadvantages for infective in vitro models and more in particular, in vivo and clinical models (Nguyen TH, et al. PLoS Negl Trop Dis 2017;11(2):e0005389). With these chemical variations in favipiravir structure, we found that the modulation of the tautomer via 6-substitution did not provide an improvement in the antiviral response, whereas interestingly, from 3-O-functionalization, we found that the acetylation is a convenient removal moiety because it generated a compound 2-fold more active than favipiravir with a better selectivity against bovine and human model of coronavirus. Also, we demonstrated through NMR and fluorometric analysis that the diacetylated compound released in short time the favipiravir, being the acetylation a convenie